APPI Joins Initiative to Transform Clinical Trials
The Academy of Pharmaceutical Physicians and Investigators (APPI), a nonprofit group of nearly 1,200 physician members involved in the clinical research enterprise, has joined the Clinical Trials Transformation Initiative (CTTI).
APPI Joins Initiative to Transform Clinical Trials
Alexandria, Va.-The Academy of Pharmaceutical Physicians and Investigators (APPI), a nonprofit group of nearly 1,200 physician members involved in the clinical research enterprise, has joined the Clinical Trials Transformation Initiative (CTTI).
The CTTI was founded recently by the U.S. Food and Drug Administration (FDA) and Duke University as a public-private partnership of organizations that seeks to improve the quality and efficiency of clinical trials in the United States. As described at https://www.trialstransformation.org, CTTI was formed in the wake of growing frustration among patients, consumers, the academic community, and industry over the difficulty of conducting high-quality clinical trials in a timely manner that could produce information physicians need to define optimal treatments for their patients.
“As the leaders of the clinical research teams that test the safety and efficacy of potential new drugs and devices, physician investigators are in the prime position to spearhead efforts to make the trials process work better,” says Charles M. Alexander, MD, FACP, FACE, president-elect of APPI. “Our goal in joining CTTI is to support its collaborative efforts on behalf of everyone from the human subject volunteers in clinical trials to the researchers to the patients who will benefit in the future from FDA-approved products.”
As a contributing member of CTTI, APPI will choose one representative from among its membership to serve on CTTI’s Steering Committee. The Steering Committee representative from APPI may nominate other individuals from within APPI to work on project teams or special interest groups, should they be formed.
APPI is an affiliate of the Association of Clinical Research Professionals (ACRP), an Alexandria, Va.-based nonprofit group with nearly 20,000 members worldwide from the clinical research team. Prior to its affiliation with ACRP in 2005, APPI had been known as the American Academy of Pharmaceutical Physicians. APPI has chapters in California, District of Columbia, Illinois, Kansas, Massachusetts, New Jersey, North Carolina, and Pennsylvania, and is the certification body offering the Certified Physician Investigator (CPI™) examination.
For more information about APPI, please visit http://www.appinet.org.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
